Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • QBTS vs MRNA✓SelectedUSD · MRNAQBTS vs MRNA performance historyLatest closeAs of-4.94%11/19
Stock and ETF performance explorer

QBTS vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-59.8%
MRNA return
+318.7%
Excess return
-378.5%
Maximum drawdown
-75.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 6mo.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-4.9%+1.3%-6.2%-5.0%
7D-25.7%-13.8%-11.9%-25.3%
30D-37.9%-17.7%-20.3%-37.4%
3M-62.2%+14.3%-76.5%-62.2%
6M-59.8%+336.0%-395.8%-58.2%
All-59.8%+318.7%-378.5%-58.2%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 6mo: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

6mo analysis · Full analysis span regression · 6 months rolling